Skip to search formSkip to main contentSkip to account menu

Camurati Engelmann disease, type 2

Known as: CAEND2, CAMURATI-ENGELMANN DISEASE, TYPE 2, Progressive diaphyseal dysplasia with striations of the bones 
National Institutes of Health

Related topics

Related topics

3 relations
Autosomal dominant inheritancePorokeratosis, Disseminated Superficial Actinic

Broader (1)

Camurati-Engelmann Syndrome

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2002
2002
Domain-specific mutations of a transforming growth factor(TGF)-β1 latency-associated peptide cause Camurati-Engelmann disease because of the formation of a constitutively active form of TGF-β1
Highly Cited
2001
Highly Cited
2001
Domain-specific Mutations of a Transforming Growth Factor (TGF)-β1 Latency-associated Peptide Cause Camurati-Engelmann Disease Because of the Formation of a Constitutively Active Form of TGF-β1*
Transforming growth factor (TGF)-β1 is secreted as a latent form, which consists of its mature form and a latency-associated… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)